What does CUSIP 86889P117 represent in this 13F holders report?

CUSIP 86889P117 is the security identifier for SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 used to aggregate holder disclosures.

How many institutions held SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 in Q3 2021?

17 institutional investors reported SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 for Q3 2021. Use the holders table for investor-level position and value details.

203 (SRZNW)

CUSIP: 86889P117

Q3 2021 13F Holders as of 30 Sep 2021

Security type / class: Equity / *W EXP 08/01/203
Total 13F shares: 3,838,117
Total 13F value: $4,313,000
Share change: +3,838,117
SEC-reported price per share: $1.14
Number of holders: 17
Value change: +$4,313,000
Number of buys: 17

Security key

86889P117

Report period

Q3 2021

Institutions

Top holders

SRZNW full security history Ownership snapshot Full 13F holder table Surrozen, Inc./DE SEC filings Surrozen, Inc./DE company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SRZNW - Surrozen, Inc./DE - *W EXP 08/01/203 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Benny Soffer

Disclosed value leader

Benny Soffer

Comparable rows

0/6

Latest evidence

11 Aug 2021

3/4/5 Highest disclosed value: $716,300 6 rows are not safely comparable across share classes.

Quick read

Benny Soffer has the largest disclosed position value at $716.3K.

0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Benny Soffer's linked filing trail.

Disclosed position value Top 5

Benny Soffer $716.3K

Kevin Harold Livingston $716.3K

Life Sciences Consonance $716.3K

Christopher Haqq $11.4K

Donald J. Santel $11.4K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 6 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Benny Soffer	3/4/5 FORMER DIRECTOR 3/4/5	— mixed-class rows	$716,300 2,029,667 shares mixed-class rows	—	11 Aug 2021
Kevin Harold Livingston	3/4/5 Former Chief Financial Officer 3/4/5	— mixed-class rows	$716,300 2,029,667 shares mixed-class rows	—	11 Aug 2021
Life Sciences Consonance	3/4/5 Former 10% Holder 3/4/5	— mixed-class rows	$716,300 2,029,667 shares mixed-class rows	—	11 Aug 2021
Christopher Haqq	3/4/5 Former Director 3/4/5	— denominator unverified	$11,400 30,000 shares	—	11 Aug 2021
Donald J. Santel	3/4/5 Former Director 3/4/5	— denominator unverified	$11,400 30,000 shares	—	11 Aug 2021
Jennifer Jarrett	3/4/5 Former Director 3/4/5	— denominator unverified	$11,400 30,000 shares	—	11 Aug 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,838,117

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

Q3 2021 holders

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 value	Q3 2021 value	Value change	Value Chg %